Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb News) – The government of Ontario recently announced about C$7 million (US$6.7 million) in new funding for four large-scale genomics projects.

NEW YORK (GenomeWeb News) – A shareholder is suing Sequenom and its board, alleging they breached their fiduciary duty and damaged the company by implementing an illegal strategy to drive up orders of the MaterniT21 Plus non-invasive prenatal diagnostic test.

NEW YORK (GenomeWeb News) – Pacific Biosciences today announced an agreement with Roche Diagnostics to develop diagnostic products based on PacBio's SMRT technology.
Including upfront, milestone, and supply payments, the deal is potentially worth more than $75 million to PacBio.

NEW YORK (GenomeWeb News) – Illumina said today that it will partner with Global Genomics Group (G3) to provide whole-genome sequencing for the Genetic Loci and the Burden of Atherosclerotic Lesions, or GLOBAL, clinical trial.

NEW YORK (GenomeWeb News) – Privately held Chinese diagnostics services firm iGenomics has purchased 17 of Life Technologies' Ion Proton next-generation sequencing systems and has agreed to add 15 more machines by the end of the year, Life Tech said today.

NEW YORK (GenomeWeb News) – A team of clinical researchers in Vancouver has received C$5 million (US$4.8 million) in new funding to use next-generation sequencing to improve methods for testing for drug resistance in HIV/AIDS patients, Genome British Columbia said today.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said it has reached a deal with Fleury Medicina e Saude (Fleury Group) to provide Ariosa's non-invasive prenatal diagnostic test in Brazil.

NEW YORK (GenomeWeb News) – Natera and LifeLabs Medical Laboratory Services today announced a deal to distribute the Panorama non-invasive prenatal diagnostic test in Canada.

NEW YORK (GenomeWeb News) – French biomarker firm Skuldtech today announced it has been awarded €1 million ($1.3 million) in funding to support work on developing diagnostic tests for an Alzheimer's drug in development.

NEW YORK (GenomeWeb News) – Life Technologies today announced the Ion AmpliSeq Exome Certified Service Provider program and its first members.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.